Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation

NCT: NCT02052271 · COMPLETED

NCT IDNCT02052271
StatusCOMPLETED
Start Date2014-06-03
Completion2018-03-27

Brief Summary

The purpose of this study is to determine whether transcranial cathodal direct current stimulation (tDCS) delivered over the cerebellum can improve essential tremor.

Frequently Asked Questions

What is Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation?

Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation is a clinical trial registered under NCT02052271. Current status: COMPLETED.

What is the status of NCT02052271?

The current status of NCT02052271 (Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation) is: COMPLETED.

When did Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation start?

Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation started on 2014-06-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑